Logo Image
|Podcasts|August 10, 2021

Exploring 2022 Trends in Health and Hospital Drug Spending With Vizient

Vizient recently released its Summer 2021 Pharmacy Market Outlook, which projects pharmaceutical spending for 2022 based on an analysis of its members' data. On this episode of Managed Care Cast, we talk about some of the findings.

What’s ahead for hospitals and health systems in projected drug spending for 2022?

Vizient recently released its Summer 2021 Pharmacy Market Outlook, which looks at what purchasers can expect next year. The report, which delves into its members’ purchasing patterns, predicts a 3.1% increase in pharmaceutical spending next year, with oncology drugs accounting for about 25% of the increase. The report also discusses increasing competition from biosimilars, including the recent approval of insulin glargine as an interchangeable biosimilar for the treatment of diabetes; the practice of white bagging; and other issues.

On this episode of Managed Care Cast, we speak with Steven Lucio, PharmD, BCPS, senior principal, Pharmacy Solutions, about the report, which also discusses the continued impact of COVID-19 on health care.

Listen above or through one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Related to this article

View more
Anthony Stein, MD | Image: City of Hope
How Capitation and Crowded EDs Shape Who Gets Access to Menin Inhibitors in AML
At an AJMC® Stakeholder Interchange in Los Angeles, leukemia specialists described a region where hospital formularies push menin inhibitor starts into the clinic, emergency department (ED) physicians may not recognize differentiation syndrome, and capitated insurance contracts steer some patients with acute myeloid leukemia away from academic centers.
Read more